Showing results (451-460 of 519) with videos related to

Sort By:
Pageof 52
Medicina Clinica|December 13, 2021
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF ProgramJosé L López-Sendón, David Alonso-Rodríguez, Gonzalo Barón-Esquivias, et al.
International Journal of Cardiology. Heart & Vasculature|November 16, 2020
Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registrySergio Dubner, José Francisco Kerr Saraiva, Juan Carlos Nunez Fragoso, et al.
Journal of Neurosurgery|March 1, 1988
Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhageE S Flamm, H P Adams, D W Beck, et al.
Stroke|August 26, 1998
Hypertension and its treatment in the NINDS rt-PA Stroke TrialT Brott, M Lu, R Kothari, et al.
The Journal of Biological Chemistry|April 17, 2014
Inactivation of the transcription factor GLI1 accelerates pancreatic cancer progressionLisa D Mills, Lizhi Zhang, Ronald Marler, et al.
Journal of Autism and Developmental Disorders|March 15, 2017
Association of Rigid-Compulsive Behavior with Functional Constipation in Autism Spectrum DisorderSarah Marler, Bradley J Ferguson, Evon Batey Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancerPaul J Mills, Barbara Parker, Vicky Jones, et al.
Stroke|April 1, 1989
Morning increase in onset of ischemic strokeJ R Marler, T R Price, G L Clark, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Pageof 52